Company Filing History:
1 out of 10 
1 out of 197 
Years Active: 2024
Title: Laura Maria Teresa Capelli: Innovator in Prostate Cancer Risk Assessment
Introduction
Laura Maria Teresa Capelli is a distinguished inventor based in Milan, Italy. She has made significant contributions to the field of medical diagnostics, particularly in assessing the risk of prostate cancer. Her innovative approach utilizes advanced sensor technology to analyze urine samples, providing valuable insights into cancer risk.
Latest Patents
Laura holds a patent for "Methods to assess the risk of being affected by prostate cancer." This patent discloses methods for evaluating the likelihood that a male subject is affected by prostate cancer and determining the aggressiveness of such cancer. The methods involve analyzing the gaseous headspace of urine samples using at least three metal oxide semiconductor-based gas sensors. The first sensor utilizes pure or doped SnO, the second sensor employs pure or doped ZnO, and the third sensor incorporates pure or doped SnO, pure or doped TiO, and pure or doped NbO. She has 1 patent to her name.
Career Highlights
Throughout her career, Laura has worked with notable organizations, including Humanitas Mirasole S.p.a. and Politecnico di Milano. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in cancer diagnostics.
Collaborations
Laura has collaborated with esteemed colleagues such as Gianluigi Taverna and Fabio Grizzi. Their combined expertise has further advanced the research and development of innovative diagnostic methods.
Conclusion
Laura Maria Teresa Capelli is a pioneering inventor whose work in prostate cancer risk assessment exemplifies the intersection of technology and healthcare. Her contributions are vital in the ongoing fight against cancer, showcasing the importance of innovation in medical research.